Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GTx-758 vs Lupron in Advanced Prostate Cancer
NCT01326312Phase 2Terminated
- Sponsor
- GTx
- Start
- Jun 2011
- Primary completion
- Dec 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of GTx-758 in prostate cancer (PCa), sponsored by GTx. Started Jun 2011; status: terminated.
02
Drugs
GTx-758
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01326312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01326312.